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Abstract Extracorporeal membrane oxygenation (ECMO) is a rescue therapy for
patients with cardio-respiratory failure. Establishing, maintaining and weaning
from ECMO may increase the risk for intracranial injury. We used a dual channel
near infrared system to monitor cerebral and peripheral tissue oxygenation in 3
venoarterial (VA) and 1 venovenous (VV) ECMO patients undergoing manipula-
tions in the ECMO circuit flows. Spectral analysis was performed on the oxyhae-
moglobin data collected from these patients with the aim of comparing oscillations
at range of frequencies appearing in the two measurement sites.
1 Introduction
Extracorporeal membrane oxygenation (ECMO) is a life support system in child-
ren with intractable cardio-respiratory failure. It is aimed at supporting the heart
and lungs temporarily whilst giving them a chance to recover. As ECMO is used
in patients who are otherwise likely to die, the results focus on survival. However,
28-52% of these patients show abnormal neuro-imaging related both to pre-
ECMO events and to the ECMO procedure itself [1]. There are 2 forms of ECMO
support–venoarterial (VA) ECMO and venovenous (VV) ECMO. Establishing VA
ECMO involves cannulation of major vessels in the neck–right common carotid
artery (RCCA) and internal jugular vein–and supports both heart and lungs. VV
ECMO involves supporting only the lungs and does not involve cannulation of the
RCCA. The ECMO system can operate using 2 types of blood pumps: 1) A centri-
fugal pump which uses a high speed rotating device that pulls the blood into the
pump and then accelerates it radially outwards and 2) a roller pump which com-
presses the cannula, thereby pushing the blood through the circuit. Maintaining2
and weaning from ECMO requires manipulation of ECMO flows, which can af-
fect cerebral blood flow and potentially lead to neurologic complications.
Near infrared spectroscopy (NIRS) offers a continuous, non invasive means of
monitoring cerebral oxygenation. Ejike et al. [2] report the use of NIRS on ECMO
patients during ligation of the RCCA and during variations in the ECMO circuit
flows. They concluded that regional cerebral oxygenation is not primarily affected
by alterations in flows but did demonstrate a significant decrease in right sided ce-
rebral oxygenation during ligation. Previous studies using NIRS to evaluate the
effects of vessel ligation showed a decrease in oxy-(HbO2) and increase in deoxy-
(HHb) haemoglobin in the right hemisphere [3] and in both hemispheres [4].
The long-term aim is to use an optical topography system to investigate topo-
graphic cerebral oxygenation changes in patients undergoing ECMO. However in-
itially we are monitoring regional cerebral and peripheral tissue oxygenation using
a dual channel system, with the aim of investigating the relationship between brain
and peripheral tissue oxygenation during changes in ECMO related variables.
2 Methods
Studies were performed on 4 ECMO patients, aged between 1 day and 5 years.
The patient group in this pilot study is a rather inhomogeneous group consisting of
2 VA ECMO cases operating on centrifugal pumps, 1 VA ECMO and 1 VV
ECMO operating on roller pumps.
A dual channel near infrared system (NIRO 200, Hamamatsu Photonics KK)
was used to measure changes in HbO2 and HHb haemoglobin concentrations using
the modified Beer-Lambert Law, and tissue oxygenation index (TOI) using spa-
tially resolved spectroscopy. Channel 1 was placed on the forehead (cerebral) and
channel 2 on the calf (peripheral) of the patients. The optodes were held in place
using elastic bandage to eliminate possible drifts in the signal arising from gradual
loss in contact between the optode and the skin. For the conversion of the optical
attenuation changes to chromophore concentration changes a differential path-
length factor (DPF) of 4.99 was applied [5]. Data were collected during manipu-
lations in the ECMO circuit flow. Blood flow in the ECMO circuit was decreased
or increased successively by 10% from the initial flow every 20-30 min.
The data were divided into sections for each specific flow. Power spectral den-
sity (PSD) and coherence analysis were performed on the HbO2 signal recorded at
the two measurement sites. The PSDs were obtained in order to identify the pres-
ence of any oscillations occurring in the brain and in the leg and were estimated
using Welch’s method [6]. The coherence function was used to characterise the
frequency dependent correlation of the HbO2 signal in the brain with the HbO2
signal in the leg. We defined three frequency bands (very low (VLF) 0.002-0.3
Hz, low (LF) 0.3-0.5 Hz and high (HF) 0.5-1 Hz) to extract vasomotion, respirato-
ry and cardiac oscillations. To obtain a measure of the coherence over a specific
frequency band, the coherence function was averaged over that frequency band.3
3 Results and Discussion
Figure 1 (a) shows the oscillatory changes in HbO2 and (b) the corresponding
PSDs during weaning for Patient 1 undergoing VA ECMO. When a patient is
weaned off ECMO the blood flow in the ECMO circuit is reduced by 10% approx-
imately every 30 minutes while the heart and lungs of the patient are gradually al-
lowed to take over. In this case, the ECMO circuit operated on a roller pump.
The PSDs show the presence of a strong oscillation in the brain and leg that
remains constant as the ECMO circuit flow is decreased, corresponding to the pa-
tient’s respiration rate (RR). A higher frequency appears in both the brain and leg
that shifts to the left with decreasing ECMO circuit flow. This frequency is twice
the frequency of the pump (fpump) in the ECMO circuit, which is consistent with
the two headed roller pump. In addition, a very slow oscillation (~0.005 Hz) is
present only in the leg. The strength of this oscillation appears to be increasing as
the flow is reduced and can be clearly seen even in the time domain plots. This
observation raises questions about the relationship between cerebral and systemic
vascular vasomotion and whether cerebral autoregulation results in suppressing
this oscillation in the brain. The coherence between the brain and leg at 90%, 80%
and 70% initial flow in the VLF and LF bands was significantly different (p<0.05)
from the coherence at initial flow in these frequency bands. Also, there was an in-
crease in coherence in association with reduction in ECMO flows.
Figure 2 shows a) the changes in HbO2 data and b) the corresponding PSDs for
Patient 2, undergoing VA ECMO on a centrifugal pump. The PSDs of this patient
showed the presence of two oscillations, one in the LF band corresponding to the
patient’s RR and the other in the HF band corresponding to the patient’s heart rate
(HR). There is no indication of the pump frequency in these data. However, we
can identify oscillations in the VLF band. In comparison with the previous patient
these oscillations occur around 0.015 Hz and appear only in the brain and not in
the leg. The coherence between the brain and leg at 90% and 80% initial flow in
the VLF, LF and HF bands was significantly different (p<0.05) from the cohe-
rence at initial flow in these frequency bands. This is in contrast with Patient 1,
who showed a decrease in coherence with reduction in ECMO flows.
Spectral analysis was performed on another patient undergoing VA ECMO
with a centrifugal pump (Patient 3). The PSDs, shown in Figure 3(b) identify the
RR and the HR. Similar to the results of patient 1, the PSD of this patient showed
the presence of oscillations (~0.005 Hz) in the leg and not in the brain.
Figure 4(a) shows the changes in HbO2 data of a patient undergoing VV
ECMO with a roller pump (Patient 4). The corresponding PSDs are shown in fig-
ure 4(b) with the RR and the HR present in both brain and leg. Two more oscilla-
tions were identified; ~0.005 Hz appearing in the leg only and ~0.05 Hz appearing
in the brain only. The difference between the oscillations in the VLF range can be
clearly seen even in the time domain plots.4
4 Conclusions
NIRS is an effective technique for monitoring cerebral oxygenation in ECMO pa-
tients. We have used PSDs to identify the presence of any oscillations occurring in
the brain and leg of 4 ECMO patients undergoing flow manipulations. The RR and
HR can be picked up in all patients and is present in both brain and leg. In addition
to these oscillations, we identified the presence of oscillations in the VLF band. It
is interesting that a low frequency oscillation (0.005Hz) was present in the leg data
of 3 of the 4 patients studied (2 VA ECMO patients and 1 VV ECMO patient).
Kvandal et al. report the presence of skin vasomotion oscillations in the interval
0.005-0.0095 Hz [7]. Two of the patients showed slow oscillations in the brain
(~0.015Hz in Patient 2 and ~0.05Hz in Patient 4), similar to those described by
Obrig et al. [8]. Oscillations in the HF band appearing at twice the frequency of
the ECMO pump were detected in brain and leg for Patient 1 (VA ECMO on roll-
er pump). There was not clear relationship between the origin of the oscillation
and the patients’ clinical condition.
Further studies are required to more fully explore the relationship between os-
cillations arising in specific frequency bands and the type of ECMO procedures
used in different patients. These studied may elucidate cerebral autoregulation
mechanisms in ECMO patients.
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Fig. 1 (a) Changes in HbO2 data in the brain and leg for Patient 1, during reduction in the ECMO
circuit blood flow. (b) Corresponding power spectral density.
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Fig. 2 (a) Changes in HbO2 data in the brain and leg for Patient 2, during reduction in the ECMO
circuit blood flow. (b) Corresponding power spectral density.
Fig. 3 (a) Changes in HbO2 data in the brain and leg for Patient 3. (b) Corresponding power
spectral density.
Fig. 4 (a) Changes in HbO2 data in the brain and leg for Patient 4. (b) Corresponding power
spectral density.
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